Cai Lay Veterinary Pharmaceutical updates record date for shareholder opinions

Cai Lay Veterinary Pharmaceutical Joint Stock Company (HNX:MKV) announced on September 25, 2025, a replacement of its previous information disclosure regarding the record date for collecting shareholder opinions in writing. The company had initially published Notice No. 19/2025/TB-MKV on September 15, 2025. Due to content adjustments and to update the exact timeline for obtaining written shareholder feedback, the company subsequently issued an amended Notice No. 19/2025/TB-MKV on September 18, 2025.

The revised notice, dated September 18, 2025, is now officially the definitive information, superseding the prior version. The company has formally requested the Hanoi Stock Exchange (HNX) to acknowledge the September 18, 2025, notice as the official communication. Cai Lay Veterinary Pharmaceutical JSC commits to the accuracy and truthfulness of the disclosed information and affirms that this replacement does not affect the legal rights of shareholders, complying with all current legal regulations.

The purpose of the shareholder consultation is to establish a subsidiary, provisionally named "Cai Lay Veterinary Pharmaceutical One Member Limited Company." The record date for collecting shareholder opinions in writing is set for October 8, 2025. The implementation period for gathering these opinions will run from October 17, 2025, until 4:30 PM on October 31, 2025. Each share grants one voting right, and the consultation will take place at the company's office.